nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.02.2014 | Original Article

Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections

verfasst von: P. A. Erba, G. Leo, M. Sollini, C. Tascini, R. Boni, R. N. Berchiolli, F. Menichetti, M. Ferrari, E. Lazzeri, G. Mariani

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In this study we evaluated the diagnostic performance of ^99mTc-HMPAO-leucocyte (^99mTc-HMPAO-WBC) scintigraphy in a consecutive series of 55 patients (46 men and 9 women, mean age 71 ± 9 years, range 50 – 88 years) with a suspected late or a low-grade late vascular prosthesis infection (VPI), also comparing the diagnostic accuracy of WBC with that of other radiological imaging methods.

Methods

All patients suspected of having VPI underwent clinical examination, blood tests, microbiology, US and CT, and were classified according to the Fitzgerald criteria. A final diagnosis of VPI was established in 47 of the 55 patients, with microbiological confirmation after surgical removal of the prosthesis in 36 of the 47. In the 11 patients with major contraindications to surgery, the final diagnosis was based on microbiology and clinical follow-up of at least 18 months.

Results

^99mTc-HMPAO-WBC planar, SPECT and SPECT/CT imaging identified VPI in 43 of 47 patients (20 of these also showed infection at extra-prosthetic sites). In the remaining eight patients without VPI, different sites of infections were found. The use of SPECT/CT images led to a significant reduction in the number of false-positive findings in 37 % of patients (sensitivity and specificity 100 %, versus 85.1 % and 62.5 % for stand-alone SPECT). Sensitivity and specificity were 34 % and 75 % for US, 48.9 % and 83.3 % for CT, and 68.1 % and 62.5 % for the FitzGerald classification. Perioperative mortality was 5.5 %, mid-term mortality 12 %, and long-term mortality 27 %. Survival rates were similar in patients treated with surgery and antimicrobial therapy compared to patients treated with antimicrobial therapy alone (61 % versus 63 %, respectively), while infection eradication at 12 months was significantly higher following surgery (83.3 % versus 45.5 %).

Conclusion

^99mTc-HMPAO-WBC SPECT/CT is useful for detecting, localizing and defining the extent of graft infection in patients with late and low-grade late VPI with inconclusive radiological findings. ^99mTc-HMPAO-WBC SPECT/CT might be used to optimize patient management.

Lorentzen JE, Nielsen OM, Arendrup H, Kimose HH, Bille S, Andersen J, et al. Vascular graft infection: an analysis of 62 graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery. 1985;98(1):81–6.PubMed

FitzGerald SF, Kelly C, Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother. 2005;56(6):996–9.PubMedCrossRef

Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case – control study. J Infect. 2006;53(1):49–55.PubMedCrossRef

Legout L, Sarraz-Bournet B, D’Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 2012;18(4):352–8.PubMedCrossRef

Valentine RJ. Diagnosis and management of aortic graft infection. Semin Vasc Surg. 2001;14(4):292–301.PubMedCrossRef

Lorenz U, Schäfer T, Ohlsen K, Tiurbe GC, Bühler C, Germer CT, et al. In vivo detection of Staphylococcus aureus in biofilm on vascular prostheses using non-invasive biophotonic imaging. Eur J Vasc Endovasc Surg. 2011;41(1):68–75.PubMedCrossRef

Hicks RC, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg. 1997;14 Suppl A:5–9.PubMedCrossRef

Calligaro KD, Veith FJ, Schwartz ML, Dougherty MJ, DeLaurentis DA. Differences in early versus late extracavitary arterial graft infections. J Vasc Surg. 1995;22(6):680–5; discussion 5–8.PubMedCrossRef

Szczot M, Meybeck A, Legout L, Pasquet A, Van Grunderbeeck N, Langlois J. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect. 2011;62(3):204–11.PubMedCrossRef

10.

Société de Pathologie Infectieuse de Langue Française (SPILF), et al. Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Med Mal Infect. 2010;40(4):185–211.CrossRef

11.

Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645–54.PubMedCrossRef

12.

Taylor J. The 2009 ESC Guidelines for management of infective endocarditis reviewed. Eur Heart J. 2009;30(19):2185–6.PubMedCrossRef

13.

Low RN, Wall SD, Jeffrey Jr RB, Sollitto RA, Reilly LM, Tierney Jr LM. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990;175(1):157–62.PubMed

14.

Orton DF, LeVeen RF, Saigh JA, et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics. 2000;20(4):977–93.PubMedCrossRef

15.

Haaga JR, Baldwin GN, Reich NE, Beven E, Kramer A, Weinstein A, et al. CT detection of infected synthetic grafts: preliminary report of a new sign. AJR Am J Roentgenol. 1978;131(2):317–20.PubMedCrossRef

16.

O’Hara PJ, Borkowski GP, Hertzer NR, O’Donovan PB, Brigham SL, Beven EG. Natural history of periprosthetic air on computerized axial tomographic examination of the abdomen following abdominal aortic aneurysm repair. J Vasc Surg. 1984;1(3):429–33.PubMed

17.

Qvarfordt PG, Reilly LM, Mark AS, Goldstone J, Wall SD, Ehrenfeld WK, et al. Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg. 1985;150(2):227–31.PubMedCrossRef

18.

Bruggink JL, Glaudemans AW, Saleem BR, Meerwaldt R, Alkefaji H, Prins TR, et al. Accuracy of FDG-PETCT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg. 2010;40(3):348–54.PubMedCrossRef

19.

Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg. 2005;42(5):919–25.PubMedCrossRef

20.

Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M, et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg. 1993;17(1):87–95; discussion 95−6.PubMedCrossRef

21.

Bruggink JL, Slart RH, Pol JA, Reijnen MM, Zeebregts CJ. Current role of imaging in diagnosing aortic graft infections. Semin Vasc Surg. 2011;24(4):182–90.PubMedCrossRef

22.

Olofsson PA, Auffermann W, Higgins CB, Rabahie GN, Tavares N, Stoney RJ. Diagnosis of prosthetic aortic graft infection by magnetic resonance imaging. J Vasc Surg. 1988;8(2):99–105.PubMed

23.

Spartera C, Morettini G, Petrassi C, Marino G, Minuti U, Pavone P, et al. Role of magnetic resonance imaging in the evaluation of aortic graft healing, perigraft fluid collection, and graft infection. Eur J Vasc Surg. 1990;4(1):69–73.PubMedCrossRef

24.

Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47(4):587–94.PubMed

25.

Djekidel M, Brown RK, Piert M. Benefits of hybrid SPECT/CT for (111)In-oxine- and Tc-99m-hexamethylpropylene amine oxime-labeled leukocyte imaging. Clin Nucl Med. 2011;36(7):e50–6.PubMedCrossRef

26.

Lou L, Alibhai KN, Winkelaar GB, Turnbull RG, Hoskinson ME, Warshawski R, et al. 99mTc-WBC scintigraphy with SPECT/CT in the evaluation of arterial graft infection. Nucl Med Commun. 2010;31(5):411–6.PubMed

27.

Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43(10):5238–42.PubMedCentralPubMedCrossRef

28.

Perera GB, Fujitani RM, Kubaska SM. Aortic graft infection: update on management and treatment options. Vasc Endovascular Surg. 2006;40(1):1–10.PubMedCrossRef

29.

Roca M, Martín-Comín J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med. 1998;25(7):797–9.PubMedCrossRef

30.

de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with 99mTc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842–8.PubMedCentralPubMedCrossRef

31.

Palestro CJ, Brown ML, Forstrom LA, Greenspanet BS, McAfee JG, Royal HD, et al. Society of Nuclear Medicine Procedure Guideline for 99mTc-exametazime (HMPAO)-labeled leukocyte scintigraphy for suspected infection/inflammation, version 3.0, 2004. http://interactive.snm.org/docs/HMPAO_v3.pdf.

32.

O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45.PubMedCrossRef

33.

Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–9.PubMedCrossRef

34.

Munzio PJ, Reilly LM, Stoney RJ. Redo aortic grafting after treatment of aortic graft infection. J Vasc Surg. 1996;24(3):328–35.CrossRef

35.

Liberatore M, Misuraca M, Calandri E, Rizzo L, Speziale F, Iurilli AP, et al. White blood cell scintigraphy in the diagnosis of infection of endovascular prostheses within the first month after implantation. Med Sci Monit. 2006;12(3):MT5–9.PubMed

36.

Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging. 2009;53(1):35–50.PubMed

37.

Bunt TJ. Vascular graft infections: an update. Cardiovasc Surg. 2001;9(3):225–33.PubMedCrossRef

38.

Maze MJ, Laws P, Buckenham T, Pithie A, Gallagher K, Metcalf S, et al. Outcomes of infected abdominal aortic grafts managed with antimicrobial therapy and graft retention in an unselected cohort. Eur J Vasc Endovasc Surg. 2013;45(4):373–80.PubMedCrossRef

Titel: Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections
verfasst von: P. A. Erba
G. Leo
M. Sollini
C. Tascini
R. Boni
R. N. Berchiolli
F. Menichetti
M. Ferrari
E. Lazzeri
G. Mariani
Publikationsdatum: 01.02.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2014
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-013-2582-9

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours

High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT

Author’s comment on the retraction of “Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging”

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

Retraction Note: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging

Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa